ATE328897T1 - Verwendung von hev-polypeptiden - Google Patents

Verwendung von hev-polypeptiden

Info

Publication number
ATE328897T1
ATE328897T1 AT01924610T AT01924610T ATE328897T1 AT E328897 T1 ATE328897 T1 AT E328897T1 AT 01924610 T AT01924610 T AT 01924610T AT 01924610 T AT01924610 T AT 01924610T AT E328897 T1 ATE328897 T1 AT E328897T1
Authority
AT
Austria
Prior art keywords
polypeptides
hev
present
pathogenesis
vaccine
Prior art date
Application number
AT01924610T
Other languages
English (en)
Inventor
Howard A Fields
Yury E Khudyakov
Jihong Meng
Original Assignee
Us Gov Health & Human Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Health & Human Serv filed Critical Us Gov Health & Human Serv
Application granted granted Critical
Publication of ATE328897T1 publication Critical patent/ATE328897T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/28011—Hepeviridae
    • C12N2770/28111—Hepevirus, e.g. hepatitis E virus
    • C12N2770/28122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01924610T 2000-04-07 2001-04-03 Verwendung von hev-polypeptiden ATE328897T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19538000P 2000-04-07 2000-04-07

Publications (1)

Publication Number Publication Date
ATE328897T1 true ATE328897T1 (de) 2006-06-15

Family

ID=22721197

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01924610T ATE328897T1 (de) 2000-04-07 2001-04-03 Verwendung von hev-polypeptiden

Country Status (6)

Country Link
EP (1) EP1274725B1 (de)
AT (1) ATE328897T1 (de)
AU (2) AU5125001A (de)
CA (1) CA2405084C (de)
DE (1) DE60120391T2 (de)
WO (1) WO2001077156A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002349727B2 (en) * 2001-11-08 2008-10-16 Beijing Wantai Biological Pharmacy Enterprise Co., Ltd Hepatitis E virus monoclonal antibodies or the binding fragments of it and the use thereof
US8112798B2 (en) 2005-11-09 2012-02-07 Microsoft Corporation Hardware-aided software code measurement

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736315A (en) * 1992-10-21 1998-04-07 National Institute Of Health Methods and compositions for detecting anti-hepatitis E virus activity
US6930176B2 (en) * 1999-12-01 2005-08-16 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Major neutralization site of hepatitis E virus and use of this neutralization site in methods of vaccination and in methods of screening for neutralizing antibodies to hepatitis E virus

Also Published As

Publication number Publication date
WO2001077156A3 (en) 2002-05-10
WO2001077156A2 (en) 2001-10-18
EP1274725A2 (de) 2003-01-15
AU5125001A (en) 2001-10-23
EP1274725B1 (de) 2006-06-07
DE60120391T2 (de) 2007-06-06
CA2405084A1 (en) 2001-10-18
DE60120391D1 (de) 2006-07-20
CA2405084C (en) 2011-06-14
AU2001251250B2 (en) 2006-01-19

Similar Documents

Publication Publication Date Title
EP0794797A4 (de) Methoden und zubehör zur immunisierung von wirtsorganismen durch verabreichung nackter polynucleotide , welche für antigene peptide codieren
ATE135747T1 (de) Für das t-zell oberflächenprotein t4 kodierende dna und verwendung von t4-fragmenten bei der behandlung von aids
EE200200709A (et) Liitvalku sisaldava kompositsiooni ning seda liitvalku ja liitpolüpeptiidi kodeeriva nukleiinhappe kasutamine
ATE373092T1 (de) Zusammensetzungen und verfahren zur behandlung von chlamydia-infektionen
NO933126D0 (no) Loeselige ligander for cd40
BR0213786A (pt) Peptìdeos efetivos no tratamento de tumores e outras condições que requerem a remoção ou destruição de células
TR200001709T2 (tr) Yeni neisseria meningitids yüzey proteini
DE69637914D1 (de) Impstoff gegen den für atemwegs- und reproduktionserkrankungen beim schwein verantwortlichen virus
DE69934967D1 (de) Verfahren zur verminderung der immunogenität von proteinen
DE60140773D1 (de) Polypeptide zur Bindung an das B-Lymphozyten-stimulatorische Protein (BLyS)
NO20012812L (no) Vaksinesammensetning og vaksine samt anvendelse av polypeptid og polynukletid
ATE371373T1 (de) Durch polynukleinsäuren vom reproduktiven und respiratorischen syndromvirus des schweines kodierte proteine
ECSP024257A (es) Proteinas antigenas del virus de la enfermedad de la mancha blanca en el camaron y usos de las mismas
DE60125537D1 (de) Zusammensetzung zur diagnose und behandlung von herpes simplex virusinfektionen
ATE432287T1 (de) Peptidfragmente mit den zelltod verhindernder aktivität
ATE448793T1 (de) Rekombinante hybrid-allergenkonstrukte mit verringerter allergenität unter beibehaltung der immunogenität des natürlichen allergens
DE60120391D1 (de) Verwendung von hev-polypeptiden
DE60029327D1 (de) Nukleinsaüre- und aminosaürensequenzen von infectious salmon anaemia virus, und deren verwendung als impfstoffe
ATE283281T1 (de) T-zell epitope des raygraspollen-allergens
DK0426314T3 (da) HIV-relaterede peptider
WO1998023752A3 (de) Papillomviren, mittel zu deren nachweis sowie zur therapie von durch sie verursachten erkrankungen
EA199700353A1 (ru) Композиция и способ для определения приобретенного синдрома иммунодефицита, способ приготовления названной композиции
DE60041985D1 (de) Zusammensetzungen und verfahren zur erfassung von stress induzierten proteinen
ATE530651T1 (de) Leishmania antigene für verwendung in der therapie und diagnose von leishmaniose

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties